ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ALVR AlloVir Inc

0.80
0.002 (0.25%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
AlloVir Inc NASDAQ:ALVR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.002 0.25% 0.80 0.7803 0.80 0.8098 0.7801 0.781 215,114 00:58:29

Alvarion (in Receivership and Interim Liquidation) Announces Court Approval of Creditors' Plan

12/03/2014 9:00pm

GlobeNewswire Inc.


AlloVir (NASDAQ:ALVR)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more AlloVir Charts.

Alvarion® Ltd. (in receivership and interim liquidation) ("Alvarion" or the "Company") (OTCQB:ALVRQ) announced today that on March 11, 2014, the District Court of Tel Aviv – Yaffo approved the Company's proposed creditors plan of settlement.

The Company's creditors have 90 days or until June 15, 2014, to submit their claims to the Receiver. For additional information on submitting a claim, please contact Ms. Yael Barkai at yael@var-management.com or by fax +972-2-995-5777.

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained herein are based largely on the Company's current expectations and assumptions and are subject to a number of risks and uncertainties. The Company cautions that trading in its ordinary shares is highly speculative and poses substantial risks. The Company emphasizes that its currently outstanding ordinary shares may have limited value, and urges extreme caution with respect to any existing or future investments in its ordinary shares. In addition, there is no guarantee that the Company will be successful in keeping its ordinary shares listed on NASDAQ and consequently on the Tel Aviv Stock Exchange. The Company makes no commitment to revise or update any forward-looking statements to reflect any facts, events or circumstances after the date any such statement is made, that may bear upon such forward-looking statements.

CONTACT: Investor & Media Contacts:
         
         Elana Holzman
         ir@alvarion-ltd.com

1 Year AlloVir Chart

1 Year AlloVir Chart

1 Month AlloVir Chart

1 Month AlloVir Chart

Your Recent History

Delayed Upgrade Clock